PRFX

PainReform (PRFX)

PainReform Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PRFX

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/01/03	06:15	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:PRFX	PainReform Ltd
2025/01/03	06:06	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PRFX	PainReform Ltd
2024/12/27	22:58	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PRFX	PainReform Ltd
2024/12/27	22:30	GlobeNewswire Inc.	PainReform Provides Further Update on Phase 3 Clinical Trial of PRF-110	NASDAQ:PRFX	PainReform Ltd
2024/12/13	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PRFX	PainReform Ltd
2024/12/13	07:00	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:PRFX	PainReform Ltd
2024/12/07	06:30	Edgar (US Regulatory)	Form F-3 - Registration statement by foreign private issuers	NASDAQ:PRFX	PainReform Ltd
2024/12/05	06:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PRFX	PainReform Ltd
2024/11/20	22:50	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PRFX	PainReform Ltd
2024/11/20	22:30	GlobeNewswire Inc.	PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial	NASDAQ:PRFX	PainReform Ltd
2024/11/19	07:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PRFX	PainReform Ltd
2024/11/12	22:02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PRFX	PainReform Ltd
2024/11/08	07:00	GlobeNewswire Inc.	PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement	NASDAQ:PRFX	PainReform Ltd
2024/11/08	06:59	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PRFX	PainReform Ltd
2024/11/05	06:39	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PRFX	PainReform Ltd
2024/10/17	05:35	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PRFX	PainReform Ltd
2024/10/17	05:30	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:PRFX	PainReform Ltd
2024/10/11	06:25	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PRFX	PainReform Ltd
2024/10/04	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PRFX	PainReform Ltd
2024/10/01	05:15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PRFX	PainReform Ltd
2024/09/21	05:30	Edgar (US Regulatory)	Form F-3 - Registration statement by foreign private issuers	NASDAQ:PRFX	PainReform Ltd
2024/09/11	22:36	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PRFX	PainReform Ltd
2024/09/11	21:30	GlobeNewswire Inc.	PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110	NASDAQ:PRFX	PainReform Ltd
2024/09/10	22:46	GlobeNewswire Inc.	PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds	NASDAQ:PRFX	PainReform Ltd
2024/09/10	22:13	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PRFX	PainReform Ltd
2024/09/05	05:16	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PRFX	PainReform Ltd
2024/08/30	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PRFX	PainReform Ltd
2024/08/29	05:30	Edgar (US Regulatory)	Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]	NASDAQ:PRFX	PainReform Ltd
2024/08/28	06:07	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:PRFX	PainReform Ltd
2024/08/27	06:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PRFX	PainReform Ltd